Xeina Drugs Private Limited, a active private limited company, was established on 10 March 2017 in Noida, Uttar Pradesh, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U92100UP2017PTC159725. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rashmi Kwatra (Director), Sharda Kwatra (Additional Director). Past directors included Shas Hank Mohan, Ashish Asaf. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 302, Ocean Plaza Sector-18, Noida, Uttar Pradesh, 201301.
U92100UP2017PTC159725
159725
10 March 2017
₹0.20 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Xeina Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rashmi Kwatra | Director | 10 Mar 2017 | Current |
| Sharda Kwatra | Additional Director | 23 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Nov 2022 | Past |
| Pramod Abcsdd | Director | 24 Feb 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Xeina Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 381.13% increase. The company also saw a substantial improvement in profitability, with a 1084.46% increase in profit. The company's net worth Soared by an impressive increase of 170.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Xeina Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Xeina Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Xeina Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xeina Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Xeina Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Xeina Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
The activity Sharda Kwatra was appointed as a Additional Director was appointed as a Additional Director on 23 Feb 2018 & has been associated with this company since 7 years 9 months . was completed.
Progress on Rashmi Kwatra was appointed as a Director was appointed as a Director on 10 Mar 2017 & has been associated with this company since 8 years 9 months . was documented.
Progress on Xeina Drugs Private Limited was registered on 10 Mar 2017 with Roc Kanpur & aged 8 years 9 months as per MCA records. was documented.
The CIN of Xeina Drugs Private Limited is U92100UP2017PTC159725.
Xeina Drugs Private Limited is headquartered at 302, Ocean Plaza Sector-18, Noida, Uttar Pradesh, 201301.
Xeina Drugs Private Limited was incorporated on 10 March 2017.
The current directors of Xeina Drugs Private Limited are
The primary industry of Xeina Drugs Private Limited is Hospital And Medical Care.
Xeina Drugs Private Limited is unlisted.
The authorized capital of Xeina Drugs Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.
The compliance status of Xeina Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX